Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000991484 | SCV001142924 | uncertain significance | not provided | 2019-05-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000991484 | SCV001512022 | benign | not provided | 2024-12-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000991484 | SCV001801870 | likely benign | not provided | 2021-08-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004030122 | SCV004863983 | uncertain significance | Inborn genetic diseases | 2021-09-01 | criteria provided, single submitter | clinical testing | The c.14632C>T (p.P4878S) alteration is located in exon 71 (coding exon 71) of the ADGRV1 gene. This alteration results from a C to T substitution at nucleotide position 14632, causing the proline (P) at amino acid position 4878 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |